Polyethylene Knee Insert Reduces Oxidation Risk
By HospiMedica International staff writers Posted on 26 Apr 2017 |

Image: The E-XPE knee arthroplasty insert in PSA configuration (Photo courtesy of UOC).
A novel knee insert made of highly cross-linked polyethylene blended with vitamin E enhances wear resistance, without compromising oxidative stability and mechanical properties.
The E-XPE insert is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis (RA), osteoarthritis (OA), primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle, pseudo-gout, and post-traumatic loss of joint configuration, among others. It may also be indicated in the salvage of previously failed surgical attempts, if the knee can be satisfactorily balanced and stabilized at the time of surgery.
The single use insert is made of highly cross-linked polyethylene blended with 0.1% vitamin E, which is intended to reduce the oxidation caused by free radical generated during the sterilization irradiation process and the thermal treatment of the polyethylene insert. The E-XPE insert is a product of United Orthopedic Corporation, is available in CR, PS, UC, PSA, and patella configurations, and has been approved by the U.S. Food and Drug Administration (FDA).
“Oxidation continues to be a concern for surgeons. The E-XPE polyethylene is resistant to oxidation and performs extremely well with respect to abrasive wear resistance,” said Calvin Lin, President of United Orthopedic Corporation. “Our E-XPE polyethylene knee insert represents an important milestone in our knee portfolio.”
The majority of knee replacements consist of metal femoral and tibial components with a polyethylene liner inserted between the two articulating surfaces. Although designed to withstand the substantial forces that are transmitted across the knee joint during everyday activities, the friction generated by the articulating surfaces results in wear of the plastic liner, releasing small particles of polyethylene that activate the body’s immune system, triggering an inflammatory response and causing the bone around the knee replacement to be reabsorbed. The result is that the knee replacement becomes loose and painful, known as aseptic loosening.
The E-XPE insert is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis (RA), osteoarthritis (OA), primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle, pseudo-gout, and post-traumatic loss of joint configuration, among others. It may also be indicated in the salvage of previously failed surgical attempts, if the knee can be satisfactorily balanced and stabilized at the time of surgery.
The single use insert is made of highly cross-linked polyethylene blended with 0.1% vitamin E, which is intended to reduce the oxidation caused by free radical generated during the sterilization irradiation process and the thermal treatment of the polyethylene insert. The E-XPE insert is a product of United Orthopedic Corporation, is available in CR, PS, UC, PSA, and patella configurations, and has been approved by the U.S. Food and Drug Administration (FDA).
“Oxidation continues to be a concern for surgeons. The E-XPE polyethylene is resistant to oxidation and performs extremely well with respect to abrasive wear resistance,” said Calvin Lin, President of United Orthopedic Corporation. “Our E-XPE polyethylene knee insert represents an important milestone in our knee portfolio.”
The majority of knee replacements consist of metal femoral and tibial components with a polyethylene liner inserted between the two articulating surfaces. Although designed to withstand the substantial forces that are transmitted across the knee joint during everyday activities, the friction generated by the articulating surfaces results in wear of the plastic liner, releasing small particles of polyethylene that activate the body’s immune system, triggering an inflammatory response and causing the bone around the knee replacement to be reabsorbed. The result is that the knee replacement becomes loose and painful, known as aseptic loosening.
Latest Surgical Techniques News
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
- Novel Mechanical Heart Valve Improves Blood Flow and Lowers Risk of Blood Clots
- First-of-Its-Kind Device Replaces Mitral Valve Without Open-Heart Surgery
- Innovation in Thermographic Neurosurgical Imaging Supports Informed Decision-Making
- Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery
- Ultrasound-Activated Microstructures Clean Implanted Stents and Catheters
- First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment
Channels
Critical Care
view channel
3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
Type 1 diabetes (T1D) is a chronic condition in which the body’s immune system destroys insulin-producing cells in the pancreas, requiring patients to rely on regular insulin injections to manage blood sugar.... Read more
AI Model Predicts ICU mortality in Heart Failure Patients
Currently, heart failure has emerged as a significant complication during the later stages of various cardiovascular disorders. In the Intensive Care Unit (ICU), patients with heart failure often experience... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more